Literature cited
G. N. Kryzhanovskii, B. A. Konnikov, and M. B. Rekhtman, Zh. Nevropatol. Psikhiatr., No. 6, 720–725 (1979).
G. N. Kryzhanovskii, R. F. Makul'kin, A. A. Shandra et al., Byull. Éksp. Biol., No. 9, 281–286, (1980).
H. Möhler and T. Okada, Science,198, 849–851 (1977).
J. F. Tallman, J. W. Thomas, and D. W. Gallager, Nature,274, 383–385 (1978).
R. F. Squires and C. Braestrup, Nature,266, 732–734 (1977).
H. Möhler, P. Polc, R. Cumin et al., Nature,278, 563–565 (1979).
B. Kennedi and B. E. Leonard, Biochem. Soc. Trans.,8, 59–60 (1980).
J. M. Beaton, Experientia,32, 1036–1037 (1976).
E. Costa and P. Greengard, Adv. Biochem. Psychopharmacol.,14, (1975).
R. Tapia, M. E. Sandoval, and P. Contreras, J. Neurochem.,24, 1283–1285 (1975).
E. Roberts and S. Frankel, J. Biol. Chem.,188, 789 (1951).
R. Tapia, in: Neurohumoral Coding of Brain Function, R. D. Myers and R. R. Drucker, eds., Colin, New York (1974), pp. 2–26.
J. T. Lott, Th. Conlombe, R. V. Di Paolo et al., Neurology (Minneapolis),28, 47–54 (1978).
G. N. Kryzhanovskii, R. F. Makul'kin, and A. A. Shandra, Zh. Nevropatol. Psikhiatr., No. 4, 547–556 (1978).
G. N. Kryzhanovskii, R. F. Makul'kin, and A. A. Shandra, Byull, Éksp. Biol. Med., No. 1, 5–10 (1977).
G. N. Kryzhanovskii, R. F. Makul'kin, A. A. Shandra, et al., Byull. Éksp. Biol. Med., No. 7, 14–19 (1978).
L. Brucc and M. D. Ralston, Electroenceph. Clin. Neurophysiol.,10, 217–232 (1958).
G. N. Kryzhanovskii, Determinant Structures in the Pathology of the Nervous System [in Russian], Moscow (1980).
N. P. Bekhtereva, D. K. Kambarova, and V. K. Pozdeev, Resistant Pathological State in Brain Disorders [in Russian], Leningrad (1978).
V. N. Grafova, E. I. Danilova, and G. N. Kryzhanovskii, Byull, Éksp. Biol. Med., No. 8, 147–151 (1979).
C. L. Li, J. Neurophysiol.,22, 436–450 (1959).
D. R. Curtis, Neuropharmacology,1, 239–248 (1962).
R. Davidoff, Brain Res.,36, 218–222 (1972).
H. Meyer and D. A. Prince, Brain Res.,53, 477–482 (1973).
D. A. Prince, Exp. Neurol.,21, 467–485 (1968).
A. Guidotti, G. Toffano, and E. Costa, Nature,275, 553–555 (1978).
Y. Dudai, Brain Res.,167, 422–425 (1979).
M. K. Shellenberger, B. W. Culver, and J. H. Alderman, J. Pharmacol. Exp. Ther.,190, 341–345 (1974).
G. M. Khann, R. W. Albers, G. Sokoloff, et al., in: Inhibition in the Nervous System and Gamma-aminobutyric Acid, E. Roberts, ed., New York (1960), p. 169.
A. L. Ivanova, Activity of Pyridoxylkinase in Ontogenesis of the Human Fetus and Asphyxia of the Newborn, Author's Abstract of Candiate's Dissertation, Moscow (1972).
T. H. Clarke, B. Saunders, and B. Feldman, Am. J. Dis. Child.,133, 963–965 (1979).
M. Ebadi and B. Klangkalya, Neuropharmacology,18, 301–307 (1979).
M. Perez de la Mora, A. Feria-Velasco, and R. Tapia, J. Neurochem.,20, 1575–1587 (1973).
A. D. Hunt, J. Stokes, Jr., and W. W. McCrory, Pediatrics,13, 140–143 (1954).
F. A. Steiner, Ann. N.Y. Acad. Sci.,166, 199–209 (1969).
R. H. Glebov and G. N. Kryzhanovskii, Functional Biochemistry of Synapses [in Russian], Moscow (1978).
G. N. Kryzhanovskii, E. V. Nikushkin, V. E. Braslavskii, et al., Zh. Nevropatol. Psikhiatr., No. 1, 14–16 (1980).
G. N. Kryzhanovskii and M. N. Aliev, Zh. Nevropatol. Psikhiatr., No. 2, 225–231 (1980).
B. M. Rachkov and F. A. Ferorenkova, Experiment on Combined Treatment of Epilepsy under Specialized Institution Conditions [in Russian], Leningrad (1978), pp. 108, 111.
Author information
Authors and Affiliations
Additional information
Translated from Zhurnal Nevropatologii i Psikhiatrii imeni S. S. Korsakova, Vol. 81, No. 6, pp. 801–809, June, 1981.
Rights and permissions
About this article
Cite this article
Kryzhanovskii, G.N., Shandra, A.A. Use of nicotinamide and pyridoxal-5-phosphate in the treatment of experimental epilepsy. Neurosci Behav Physiol 15, 111–118 (1985). https://doi.org/10.1007/BF01186976
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01186976